Spinal injury patients may keep stronger bones with simple infusion
NCT ID NCT02325414
First seen Jan 04, 2026 · Last updated May 06, 2026 · Updated 16 times
Summary
This study tested whether a single dose of zoledronic acid, a drug used for osteoporosis, can prevent bone loss in people who recently had a spinal cord injury. Researchers followed 60 participants for up to two years, measuring bone density and strength. The goal was to find a practical way to protect bone health after paralysis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern University Feinberg School of Medicine
Chicago, Illinois, 60611, United States
-
Rehabilitation Institute of Chicago
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.